Gan & Lee Pharmaceuticals. (603087.SS) SHH
63.15
-1.38(-2.14%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 26.06B |
| Enterprise Value | 25.16B |
| P/E Ratio | 40.08 |
| PEG Ratio | 31.06 |
| Price/Sales Ratio | 9.8 |
| Price/Book Ratio | 3.29 |
| Enterprise/Revenue | 9.27 |
| Enterprise/EBITDA | 37.5 |
Fiscal Year
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
Profitability
| Profit Margin | 0.24 |
| Operating Margin | 0.24 |
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | 0.08 |
Income Statement
| Revenue | 3.05B |
| Revenue/Share | 6.55 |
| Gross Profit | 2.27B |
| EBITDA | 545.57M |
| Net Income | 614.66M |
| Diluted EPS | 1.04 |
Balance Sheet
| Total Cash | 3.17B |
| Total Cash/Share | 5.39 |
| Total Debt | 8.38M |
| Total Debt/Equity | 0 |
| Current Ratio | 7.2 |
| Book Value Per Share | 19.2 |
Price History
| 52-Week Change | 36.96 |
| 52-Week High | 82.25 |
| 52-Week Low | 40.4 |
| Moving Average 50 Days | 64.54 |
| Moving Average 200 Days | 66.29 |
Statistics
| Average Volume | 7.38M |
| Shares Outstanding | 597.3M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 1 |
| Trailing Annual Dividend Yield | 1.58 |
| Payout Ratio | 0.97 |
| Last Split Factor | 7:5 |
| Last Split Date | August 20, 2020 |
